Daxor Corporation is a medical device and biotechnology company that manufactures the BVA-100 blood volume analyzer, which rapidly measures human blood volume with high accuracy to support diagnosis and treatment of conditions including heart failure, kidney disease, and anemia. The company generates revenue through sales and leasing of BVA-100 instruments and sales of Volumex diagnostic kits used with the system, targeting hospitals and radiology imaging centers. Daxor also operates cryobanking services through its subsidiary Scientific Medical Systems, offering long-term storage of blood and semen for transfusion and fertility applications, and provides a Blood Optimization Program that combines blood volume measurement with frozen blood banking to reduce surgical transfusion risks.